SummaryThe mechanism of increased hepatic glucose production in obese non-insulin-dependent diabetic (NIDDM) patients is unknown. The New Zealand Obese (NZO) mouse, a polygenic model of obesity and NIDDM shows increased hepatic glucose production. To determine the mechanism of this phenomenon, we measured gluconeogenesis from U-s4C -glycerol and U-14C-alanine and relevant gluconeogenic enzymes. Gluconeogenesis from glycerol (0.07 + 0.01 vs 0.21 + 0.02 ~tmol 9 min -~ 9 body mass index (BMI) -1, p < 0.005) and alanine (0.57 + 0.07 vs 0.99 _+ 0.07 ~tmol 9 min -1 9 BMI-I,p < 0.005) was elevated in control mice NZO vs as was glycerol turnover (0.25 + 0.02 vs 0.63 + 0.09 ~tmol 9 min -1 9 BM1-1, p < 0.05). Fructose 1,6-bisphosphatase activity (44.2 + 1.9 vs 55.7 + 4.1 nmol. min-S, mg protein -s, p < 0.05) and protein levels (6.9 + 1.1 vs 16.7 + 2.3 arbitrary units, p < 0.01) were increased in NZO mouse livers, as was the activity of pyruvate carboxylase (0.12 + 0.01 vs 0.17 + 0.02 nmol-min -~ 9 mg protein -s, p < 0.05). To ascertain whether elevated lipid supply is responsible for these biochemical changes in NZO mice, we fed lean control mice a 60 % fat diet for 2 weeks. Fat-fed mice were hyperinsulinaemic (76.37 + 4.06 vs 98.00 + 7.07 pmol/1, p = 0.05) and had elevated plasma non-esterified fatty acid levels (0.44 + 0.05 vs 0.59 _+ 0.03 mmol/1, p = 0.05). Fructose 1,6-bisphosphatase activity (43.86+2.54 vs 52.93 + 3.09 nmol-min -1 -mg protein -1, p = 0.05) and protein levels (33.03 _+ 0.96 vs 40,04 + 1.26 arbitrary units, p = 0.005) and pyruvate carboxylase activity (0.10 + 0.003 vs 0.14 + 0.01 nmol. min -1 -mg protein -1, p < 0.05) were elevated in fat-fed mice. We conclude that in NZO mice increased hepatic glucose production is due to elevated lipolysis resulting from obesity. [Diabetologia (1995[Diabetologia ( ) 38: 1389[Diabetologia ( -1396